Table 3.
Geometric mean (95% CI) | Fold change from baseline* (95% CI) | p* | p (Type III)# | |
---|---|---|---|---|
MP | ||||
Baseline | 7.3 (7.0, 7.6) | |||
PD | 19.2 (13.5, 27.2) | 2.54 (1.76, 3.66) | <0.0001 | 0.072 |
PD+48 h | 17.3 (10.9, 27.4) | 2.29 (1.59, 3.3) | <0.0001 | |
PD+96 h | 30.5 (20.1, 46.1) | 4.03 (2.8, 5.81) | <0.0001 | |
LPS | ||||
Baseline | 7.2 (6.9, 7.5) | |||
PD | 15.2 (10.3, 22.5) | 2.07 (1.4, 3.06) | <0.0001 | 0.085 |
PD+48 h | 16.7 (10.8, 25.8) | 2.28 (1.54, 3.36) | <0.0001 | |
PD+96 h | 27.1 (17.0, 41.0) | 3.7 (2.51, 5.46) | <0.0001 |
Output are from mixed effects models with a random intercept for each participant. Variables for dose and visit included in the model as fixed effects.
Adjusted for challenge dose received (high or low).
P-value testing whether change from baseline is different across visits. PD, Day of paratyphoid diagnosis.